<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39416092</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>mRNA-based influenza vaccine expands breadth of B cell response in humans.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.10.10.617255</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.10.10.617255</ELocationID><Abstract><AbstractText>Eliciting broad and durable antibody responses against rapidly evolving pathogens like influenza viruses remains a formidable challenge<sup>1,2</sup>. The germinal center (GC) reaction enables the immune system to generate broad, high-affinity, and durable antibody responses to vaccination<sup>3-5</sup>. mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines induce persistent GC B cell responses in humans<sup>6-9</sup>. Whether an mRNA-based influenza vaccine could induce a superior GC response in humans compared to the conventional inactivated influenza virus vaccine remains unclear. We assessed B cell responses in peripheral blood and draining lymph nodes in cohorts receiving the inactivated or mRNA-based quadrivalent seasonal influenza vaccine. Participants receiving the mRNA-based vaccine produced more robust plasmablast responses and higher antibody titers to H1N1 and H3N2 influenza A viruses and comparable antibody titers against influenza B virus strains. Importantly, mRNA-based vaccination stimulated robust recall B cell responses characterized by sustained GC reactions that lasted at least 26 weeks post-vaccination in three of six participants analyzed. In addition to promoting the maturation of responding B cell clones, these sustained GC reactions resulted in enhanced engagement of low-frequency pre-existing memory B cells, expanding the landscape of vaccine-elicited B cell clones. This translated to expansion of the serological repertoire and increased breadth of serum antibody responses. These findings reveal an important role for the induction of persistent GC responses to influenza vaccination in humans to broaden the repertoire of vaccine-induced antibodies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matz</LastName><ForeName>Hanover C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Tae-Geun</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Thayer School of Engineering, Dartmouth College; Hanover, NH 03755, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Julian Q</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Lowrey</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Quantitative Biomedical Sciences Program, Dartmouth College; Lebanon, NH 03756, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Influenza Centre, Department of Clinical Science, University of Bergen; 5021 Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Haukeland University Hospital, 5009 Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Fangjie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Stephen C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixit</LastName><ForeName>Kritika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keplinger</LastName><ForeName>Hunter K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strnad</LastName><ForeName>Benjamin S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoegger</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Middleton</LastName><ForeName>William D</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klebert</LastName><ForeName>Michael K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Unit, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Nina H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Moderna, Inc.; Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nachbagauer</LastName><ForeName>Raffael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Moderna, Inc.; Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paris</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Moderna, Inc.; Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Jackson S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Presti</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Unit, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine; St Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Thayer School of Engineering, Dartmouth College; Hanover, NH 03755, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quantitative Biomedical Sciences Program, Dartmouth College; Lebanon, NH 03756, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellebedy</LastName><ForeName>Ali H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-6129-2532</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine; St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI089618</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM113132</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI141990</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI144616</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93021C00014</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N93019C00051</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA091842</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007172</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39416092</ArticleId><ArticleId IdType="pmc">PMC11483064</ArticleId><ArticleId IdType="doi">10.1101/2024.10.10.617255</ArticleId><ArticleId IdType="pii">2024.10.10.617255</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Servín-Blanco R., Zamora-Alvarado R., Gevorkian G. &amp; Manoutcharian K. Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Hum Vaccin Immunother 12, 2640–2648 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5085008</ArticleId><ArticleId IdType="pubmed">27295540</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuliano A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935243</ArticleId><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Garside P. et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96–99 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9651253</ArticleId></ArticleIdList></Reference><Reference><Citation>Victora G. D. &amp; Nussenzweig M. C. Germinal Centers. Annual Review of Immunology 40, 413–442 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35113731</ArticleId></ArticleIdList></Reference><Reference><Citation>Berek C., Berger A. &amp; Apel M. Maturation of the immune response in germinal centers. Cell 67, 1121–1129 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1760840</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109–113 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935394</ArticleId><ArticleId IdType="pubmed">34182569</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141–145 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9204750</ArticleId><ArticleId IdType="pubmed">35168246</ArticleId></ArticleIdList></Reference><Reference><Citation>Röltgen K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025–1040.e14 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786601</ArticleId><ArticleId IdType="pubmed">35148837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer K. et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. Cell 185, 1008–1024.e15 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808747</ArticleId><ArticleId IdType="pubmed">35202565</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappuoli R., Pizza M., Del Giudice G. &amp; De Gregorio E. Vaccines, new opportunities for a new society. Proc Natl Acad Sci U S A 111, 12288–12293 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4151714</ArticleId><ArticleId IdType="pubmed">25136130</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwickert T. A. et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 446, 83–87 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17268470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrammert J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667–671 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2515609</ArticleId><ArticleId IdType="pubmed">18449194</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F. et al. Influenza. Nat Rev Dis Primers 4, 1–21 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097467</ArticleId><ArticleId IdType="pubmed">29955068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley S. E. et al. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326, 734–736 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784927</ArticleId><ArticleId IdType="pubmed">19900932</ArticleId></ArticleIdList></Reference><Reference><Citation>Treanor John. Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift. New England Journal of Medicine 350, 218–220 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14724300</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdil C. The annual production cycle for influenza vaccine. Vaccine 21, 1776–1779 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12686093</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M., Changrob S., Li L. &amp; Wilson P. C. Imprinting, immunodominance, and other impediments to generating broad influenza immunity. Immunological Reviews 296, 191–204 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32666572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostic K. M. et al. Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics. PLoS Pathog 15, e1008109 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6922319</ArticleId><ArticleId IdType="pubmed">31856206</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntire K. M. et al. Maturation of germinal center B cells after influenza virus vaccination in humans. J Exp Med 221, e20240668 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11211068</ArticleId><ArticleId IdType="pubmed">38935072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I. T. et al. Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis. Nat Commun 14, 3631 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10279702</ArticleId><ArticleId IdType="pubmed">37336877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellebedy A. H. et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat Immunol 17, 1226–1234 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054979</ArticleId><ArticleId IdType="pubmed">27525369</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner J. S. et al. Human germinal centres engage memory and naive B cells after influenza vaccination. Nature 586, 127–132 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566073</ArticleId><ArticleId IdType="pubmed">32866963</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews S. F. et al. Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin. Immunity 51, 398–410.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31350180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat Med 22, 1456–1464 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5301914</ArticleId><ArticleId IdType="pubmed">27820605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavinder J. J. et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A 111, 2259–2264 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3926051</ArticleId><ArticleId IdType="pubmed">24469811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao A., Wang Y. T. &amp; Jost L. Entropy and the species accumulation curve: a novel entropy estimator via discovery rates of new species. Methods in Ecology and Evolution 4, 1091–1100 (2013).</Citation></Reference><Reference><Citation>Miho E. et al. Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires. Front Immunol 9, 224 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826328</ArticleId><ArticleId IdType="pubmed">29515569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rempala G. A. &amp; Seweryn M. Methods for diversity and overlap analysis in T-cell receptor populations. J Math Biol 67, 1339–1368 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543521</ArticleId><ArticleId IdType="pubmed">23007599</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials. https://investors.modernatx.com/news/news-details/2024/Moderna-Advances-Multiple-Vaccine-Programs-to-Late-Stage-Clinical-Trials/default.aspx.</Citation></Reference><Reference><Citation>Alameh M.-G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877–2892.e7 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566475</ArticleId><ArticleId IdType="pubmed">34852217</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo N. S. &amp; Lipsky P. E. Why do B cells mutate their immunoglobulin receptors? Trends Immunol 27, 374–380 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16809065</ArticleId></ArticleIdList></Reference><Reference><Citation>Purtha W. E., Tedder T. F., Johnson S., Bhattacharya D. &amp; Diamond M. S. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 208, 2599–2606 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3244041</ArticleId><ArticleId IdType="pubmed">22162833</ArticleId></ArticleIdList></Reference><Reference><Citation>Erbelding E. J. et al. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. J Infect Dis 218, 347–354 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6279170</ArticleId><ArticleId IdType="pubmed">29506129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., Ma N., Madden T. L. &amp; Ostell J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res 41, W34–40 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692102</ArticleId><ArticleId IdType="pubmed">23671333</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochet X., Lefranc M.-P. &amp; Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36, W503–508 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447746</ArticleId><ArticleId IdType="pubmed">18503082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadala-Maria D., Yaari G., Uduman M. &amp; Kleinstein S. H. Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc Natl Acad Sci U S A 112, E862–870 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4345584</ArticleId><ArticleId IdType="pubmed">25675496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N. T. et al. Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356–3358 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793929</ArticleId><ArticleId IdType="pubmed">26069265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z., Gu L., Eils R., Schlesner M. &amp; Brors B. circlize Implements and enhances circular visualization in R. Bioinformatics 30, 2811–2812 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24930139</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoehn K. B., Lunter G. &amp; Pybus O. G. A Phylogenetic Codon Substitution Model for Antibody Lineages. Genetics 206, 417–427 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5419485</ArticleId><ArticleId IdType="pubmed">28315836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoehn K. B. et al. Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination. Proc Natl Acad Sci U S A 116, 22664–22672 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6842591</ArticleId><ArticleId IdType="pubmed">31636219</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G., Smith D. K., Zhu H., Guan Y &amp; Lam T. T.-Y. ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods in Ecology and Evolution 8, 28–36 (2017).</Citation></Reference><Reference><Citation>Wolf F. A., Angerer P. &amp; Theis F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol 19, 15 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802054</ArticleId><ArticleId IdType="pubmed">29409532</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. et al. Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. Cell Host Microbe 25, 367–376.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417944</ArticleId><ArticleId IdType="pubmed">30795981</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito G. C. et al. Antibody repertoires in humanized NOD-scid-IL2Rγ(null) mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS One 7, e35497 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338711</ArticleId><ArticleId IdType="pubmed">22558161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolotin D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods 12, 380–381 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25924071</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutz D. R. et al. Proteomic identification of monoclonal antibodies from serum. Anal Chem 86, 4758–4766 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033631</ArticleId><ArticleId IdType="pubmed">24684310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>